Literature DB >> 15184379

Nucleophosmin/B23 is a candidate substrate for the BRCA1-BARD1 ubiquitin ligase.

Ko Sato1, Ryosuke Hayami, Wenwen Wu, Toru Nishikawa, Hiroyuki Nishikawa, Yoshiko Okuda, Haruki Ogata, Mamoru Fukuda, Tomohiko Ohta.   

Abstract

The breast and ovarian tumor suppressor BRCA1 forms a heterodimeric RING-type ubiquitin ligase with BARD1 to catalyze untraditional Lys-6-linked polyubiquitin chains. It is not clear how the BRCA1-BARD1 ligase regulates various cellular processes such as DNA repair, cell-cycle progression, transcriptional regulation, and centrosome duplication. Here we report that BRCA1-BARD1 catalyzes the polyubiquitination of nucleolar phosphoprotein nucleophosmin/B23 (NPM). Two different mass spectrometry screens for protein ubiquitinated by BRCA1-BARD1 both identified NPM. NPM interacts with N-terminal fragments of BRCA1 and BARD1 in a manner dependent upon BRCA1-BARD1 heterodimer formation. NPM colocalizes with BRCA1 and BARD1 in mitotic cells suggesting the possibility of NPM regulation by BRCA1-BARD1 during mitosis. BRCA1-BARD1 catalyzes the ubiquitination of NPM in vitro and in vivo, and BRCA1-BARD1 co-expression in cells causes NPM stabilization rather than degradation. This is consistent with the notion that this ligase catalyzes untraditional polyubiquitin chains. Given the many overlapped functions between NPM and BRCA1, we propose that NPM is a strong candidate as a substrate of the BRCA1-BARD1 ubiquitin ligase.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15184379     DOI: 10.1074/jbc.C400169200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  52 in total

1.  Characterization of BRCA1 protein targeting, dynamics, and function at the centrosome: a role for the nuclear export signal, CRM1, and Aurora A kinase.

Authors:  Kirsty M Brodie; Beric R Henderson
Journal:  J Biol Chem       Date:  2012-01-18       Impact factor: 5.157

2.  The UBXN1 protein associates with autoubiquitinated forms of the BRCA1 tumor suppressor and inhibits its enzymatic function.

Authors:  Foon Wu-Baer; Thomas Ludwig; Richard Baer
Journal:  Mol Cell Biol       Date:  2010-03-29       Impact factor: 4.272

3.  Quantitative proteomic identification of the BRCA1 ubiquitination substrates.

Authors:  Meihua Song; Kevin Hakala; Susan T Weintraub; Yuzuru Shiio
Journal:  J Proteome Res       Date:  2011-10-11       Impact factor: 4.466

4.  BRCA1/BARD1 inhibition of mRNA 3' processing involves targeted degradation of RNA polymerase II.

Authors:  Frida E Kleiman; Foon Wu-Baer; Danae Fonseca; Syuzo Kaneko; Richard Baer; James L Manley
Journal:  Genes Dev       Date:  2005-05-15       Impact factor: 11.361

Review 5.  Weighing in on ubiquitin: the expanding role of mass-spectrometry-based proteomics.

Authors:  Donald S Kirkpatrick; Carilee Denison; Steven P Gygi
Journal:  Nat Cell Biol       Date:  2005-08       Impact factor: 28.824

6.  Potential roles for ubiquitin and the proteasome during ribosome biogenesis.

Authors:  Diana A Stavreva; Miyuki Kawasaki; Miroslav Dundr; Karel Koberna; Waltraud G Müller; Teruko Tsujimura-Takahashi; Wataru Komatsu; Toshiya Hayano; Toshiaki Isobe; Ivan Raska; Tom Misteli; Nobuhiro Takahashi; James G McNally
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

7.  BRCA1 ubiquitinates its phosphorylation-dependent binding partner CtIP.

Authors:  Xiaochun Yu; Shuang Fu; Maoyi Lai; Richard Baer; Junjie Chen
Journal:  Genes Dev       Date:  2006-07-01       Impact factor: 11.361

Review 8.  Dissecting the ubiquitin pathway by mass spectrometry.

Authors:  Ping Xu; Junmin Peng
Journal:  Biochim Biophys Acta       Date:  2006-09-14

9.  The Nucleolus Takes Control of Protein Trafficking Under Cellular Stress.

Authors:  Narasimharao Nalabothula; Fred E Indig; France Carrier
Journal:  Mol Cell Pharmacol       Date:  2010

10.  The Histone Variant MacroH2A1 Is a BRCA1 Ubiquitin Ligase Substrate.

Authors:  Beom-Jun Kim; Doug W Chan; Sung Yun Jung; Yue Chen; Jun Qin; Yi Wang
Journal:  Cell Rep       Date:  2017-05-30       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.